Predicting risk of disability

Two articles published recently by Australian and international investigators using the MSBase database provide insight into several factors

brain scan

Case of PML

The pharmaceutical sponsor of Gilenya (fingolimod), Novartis, has this week reported one case of Progressive Multifocal Leukoencephalopathy (PML)

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

Studying MS lesions in brain tissue gives clues into genes